Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: Cross-protection against major and minor variants

Journal of Infectious Diseases

Volumn 205, Issue 12, 2012, Pages 1858-1868

  Janjua, Naveed Z ^a,b   Skowronski, Danuta M ^a,b   De Serres, Gaston ^c   Dickinson, Jim ^d   Crowcroft, Natasha S ^f,g   Taylor, Marsha ^a   Winter, Anne Luise ^f   Hottes, Travis S ^a   Fonseca, Kevin ^e   Charest, Hugues ^c   Drews, Steven J ^f   Sabaiduc, Suzana ^a   Bastien, Nathalie ^h   Li, Yan ^h   Gardy, Jennifer L ^a,b   Petric, Martin ^a,b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e Alberta Provincial Laboratory   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; EVOLUTION; GENE SEQUENCE; HEMAGGLUTINATION INHIBITION; HUMAN; INFANT; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENTINEL SURVEILLANCE; THROAT CULTURE; TREND STUDY; VACCINATION; VIRUS DETECTION; VIRUS ISOLATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CANADA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS PROTECTION; FEMALE; GENOTYPE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NASOPHARYNX; NOSE; REAL-TIME POLYMERASE CHAIN REACTION; SENTINEL SURVEILLANCE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84861563523     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis283     Document Type: Article

References (25)

1. Effectiveness of vaccine against medical consultation due to laboratoryconfirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep 2005; 31:181-91.
2. Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25:2842-51.
3. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79.
4. FluWatch: ILI definitions for the 2007-2008 season. Vol 2009. Ottawa, Canada: Public Health Agency of Canada, 2008.
5. Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG,Webster RG, Hay AJ, Malden MA, eds. Textbook of influenza. Oxford: Wiley-Blackwell, 1998.
6. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007; 33:1-38.
7. Schweiger B, Zadow I, Heckler R, Timm H, Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 2000; 38:1552-8.
8. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:1-46.
9. Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season. J Clin Virol 2009; 45:142-5.
10. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000258.
11. Canadian Community Health Survey (Cycle 3.1). Ottawa, Canada: Statistics Canada, 2005.
12. Influenza immunization coverage by province and age 2007-08. In: Table 105-0502. Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2007 boundaries) and peer groups, occasional (1209600 series). Ottawa, Canada: Statistics Canada, 2009.
13. Brownlee GG, Fodor E. The predicted antigenicity of the hemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 2001; 356:1871-6.
14. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007; CD001269.
15. Kendal AP, Pereira MS, Skethel JJ. Concepts and procedures for laboratory-based influenza surveillance. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services, Public Health Services, 1982.
16. Katz JM, Hancock K, Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther 2011; 9:669-83.
17. Cox NJ, Bender CA. The molecular epidemiology of influenza viruses. Semin Virol 1995; 6:359-70.
18. Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361:1260-7.
19. Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51: 997-1004.
20. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:155-8.
21. Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011; 29:6558-63.
22. Fleming DM, Andrews NJ, Ellis JS, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010; 64:1062-7.
23. Mook P, Pebody R, Zhao H, et al. Surveillance of influenza and other respiratory viruses in United Kingdom: October 2007 to May 2008. London: UK Health Protection Agency, 2008.
24. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Geneva: WHO, 2008.
25. Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.